Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hyperphagia × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 41 Myelodysplastic Syndromes 18 Breast Neoplasms 16 Leukemia, Myelomonocytic, Chronic 12 Neoplasms 10 Stomach Neoplasms 9 Prostatic Neoplasms 9 Carcinoma, Hepatocellular 9 Recurrence 8 Neoplasm Metastasis 7 Carcinoma, Non-Small-Cell Lung 6 Uterine Cervical Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Ovarian Neoplasms 5 Myeloproliferative Disorders 5 Multiple Myeloma 5 Lymphoma, B-Cell 5 Esophageal Neoplasms 5 Sarcoma 4 Myelodysplastic-Myeloproliferative Diseases 4 Melanoma 4 Leukemia, Biphenotypic, Acute 4 Cholangiocarcinoma 4 Thrombocythemia, Essential 3 Squamous Cell Carcinoma of Head and Neck 3 Primary Myelofibrosis 3 Polycythemia Vera 3 Pancreatic Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3

Interventions

Parenteral Nutrition 8 fish oil triglycerides 2 soybean oil, phospholipid emulsion 1 alanylglutamine 1 SMOFlipid 1 Parenteral Nutrition, Total 1 Parenteral Nutrition, Home 1 Nutrition Assessment 1 Insulin Glargine 1 Insulin 1 Injections 1 Glucose 1 Enteral Nutrition 1 DNA, Ribosomal 1 Clinical Trials as Topic 1 ClinOleic 1 Amino Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02216799 2016-02-25

GLUCOSE-in-PN

King Faisal Specialist Hospital & Research Center

Phase 4 Completed

Hyperglycemia, Hyperphagia, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡